TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27977010)

Published in Cell Death Dis on December 15, 2016

Authors

Maria R Amoroso1, Danilo S Matassa1, Ilenia Agliarulo1, Rosario Avolio1, Haonan Lu2, Lorenza Sisinni3, Giacomo Lettini3, Hani Gabra4, Matteo Landriscina3,5, Franca Esposito1

Author Affiliations

1: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Napoli, Italy.
2: Imperial College London, Ovarian Cancer Action Research Centre, Department of Cancer and Surgery, Institute of Reproductive and Developmental Biology, London, UK.
3: Laboratorio di Ricerca Preclinica e Traslazionale, IRCCS-CROB, Centro di Riferimento Oncologico Della Basilicata, Rionero in Vulture, Italy.
4: Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
5: Dipartimento di Scienze Mediche e Chirurgiche, Università Degli Studi di Foggia, Foggia, Italy.

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82

Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res (2008) 8.17

PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet (1999) 6.18

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62

Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature (2015) 4.18

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature (2015) 3.77

Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J (2010) 2.98

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene (2004) 2.67

Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40

The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res (2002) 2.24

Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal (2006) 1.87

Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci (Landmark Ed) (2009) 1.85

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer (2006) 1.68

Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis. Lancet Oncol (2002) 1.42

p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res (2008) 1.38

Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A (2013) 1.37

The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab (2013) 1.36

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest (2013) 1.28

Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene (2001) 1.26

p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene (2011) 1.21

Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology (2006) 1.20

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer. Int J Mol Sci (2013) 1.09

Developmental chemotherapy and management of recurrent ovarian cancer. J Clin Oncol (2003) 1.05

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget (2014) 1.04

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Lett (2010) 1.01

TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins. Cell Death Differ (2011) 0.96

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer. World J Gastroenterol (2012) 0.94

Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol Oncol (2013) 0.93

New insights into TRAP1 pathway. Am J Cancer Res (2012) 0.92

Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1. Cell Death Dis (2013) 0.92

The role of the transcriptional regulator snail in cell detachment, reattachment and migration. Cell Adh Migr (2009) 0.89

TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumors. Mol Oncol (2014) 0.88

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium. Mol Cancer (2012) 0.88

TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors. Cancer Res (2014) 0.88

Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil. Cancer Res Treat (2014) 0.86

p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation. Oncotarget (2014) 0.85

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ (2016) 0.84

TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways. Biochim Biophys Acta (2015) 0.82

TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review). Int J Oncol (2014) 0.81